- Home
- NVAX vs SBGI Comparison
NVAX vs SBGI Comparison
Compare NVAX & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- SBGI
- Stock Information
- Founded
- NVAX 1987
- SBGI 1986
- Country
- NVAX United States
- SBGI United States
- Employees
- NVAX N/A
- SBGI N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SBGI Broadcasting
- Sector
- NVAX Health Care
- SBGI Industrials
- Exchange
- NVAX Nasdaq
- SBGI Nasdaq
- Market Cap
- NVAX 1.3B
- SBGI 1.1B
- IPO Year
- NVAX 1995
- SBGI 1995
- Fundamental
- Price
- NVAX $6.56
- SBGI $14.10
- Analyst Decision
- NVAX Buy
- SBGI Buy
- Analyst Count
- NVAX 6
- SBGI 5
- Target Price
- NVAX $15.33
- SBGI $18.50
- AVG Volume (30 Days)
- NVAX 5.1M
- SBGI 386.5K
- Earning Date
- NVAX 08-06-2025
- SBGI 08-06-2025
- Dividend Yield
- NVAX N/A
- SBGI 7.09%
- EPS Growth
- NVAX N/A
- SBGI N/A
- EPS
- NVAX 2.97
- SBGI 1.97
- Revenue
- NVAX $1,254,962,000.00
- SBGI $3,526,000,000.00
- Revenue This Year
- NVAX $52.02
- SBGI N/A
- Revenue Next Year
- NVAX N/A
- SBGI $9.59
- P/E Ratio
- NVAX $2.21
- SBGI $7.17
- Revenue Growth
- NVAX 25.92
- SBGI 11.62
- 52 Week Low
- NVAX $5.01
- SBGI $12.07
- 52 Week High
- NVAX $15.22
- SBGI $18.46
- Technical
- Relative Strength Index (RSI)
- NVAX 40.82
- SBGI 44.41
- Support Level
- NVAX $6.93
- SBGI $14.66
- Resistance Level
- NVAX $8.46
- SBGI $15.69
- Average True Range (ATR)
- NVAX 0.34
- SBGI 0.54
- MACD
- NVAX -0.08
- SBGI -0.13
- Stochastic Oscillator
- NVAX 9.52
- SBGI 8.09
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.